Author:
Nikitin P. V.,Belyaev A. Yu.,Kobyakov G. L.,Strunina Yu. V.,Shugay S. V.,Musina G. R.,Usachev D. Yu.,Timashev P. S.
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. T. R. Izmailov, G. L. Kobyakov, S. M. Banov, et al., Primary Tumors of the Central Nervous System. Clinical Guidelines, Russian Association of Neurosurgeons, Moscow (2020).
2. Q. T. Ostrom, N. Patil, G. Cioffi, et al., “CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013–2017,” Neuro. Oncol., 22, No. 12, Suppl. 2, 1–96 (2020), https://doi.org/10.1093/neuonc/noaa200.
3. Q. T. Ostrom, H. Gittleman, G. Truitt, et al., “CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011–2015,” Neuro. Oncol., 20, Suppl. 4, 1–86 (2018), https://doi.org/https://doi.org/10.1093/neuonc/noy131.
4. G. L. Kobyakov, O. V. Absalyamova, O. Yu. Anikeeva, et al., “Practical guidelines for drug treatment of primary tumors of the central nervous system,” Zlokachestv. Opukh., 4, 55–79 (2015), https://doi.org/10.18027/2224-5057-2020-10-3s2-07.
5. E. A. Kobyakova, D. Yu. Usachev, O. V. Absalyamova, et al., “Criteria for assessing treatment responses in neuro-oncology (RANO): application in clinical trials and routine practice,” Farmateka, 28, No. 11, 21–33 (2021), https://doi.org/10.18565/pharmateca.2021.11.21-33.